The post NICE issues draft ‘no’ on first quadruplet combination for England and Wales appeared first on Myeloma UK.
Recent Content
- Combo treatment may offer new hope to astrocytoma patients: Trial
- Reduced-versus Standard-dose Melphalan as Single-agent Conditioning Regimen in Auto HSCT for Multiple Myeloma: A Systematic Review and Meta-Analysis
- Dosing begins in trial testing Enhertu for ovarian cancer
- (no title)
- (no title)
- Teclistamab combo improves relapsed, refractory myeloma outcomes
- Safety and Efficacy of Anti-B-cell Maturation Antigen (Anti-BCMA) Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Clinical Trials
- (no title)
- (no title)
- CLN-049 now has FDA fast track designation for hard-to-treat AML